Jacquelyn Perry
Foot Surgery · Fort Worth, TXNPI 1346200649
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,590 of the $7,352 with a category attached, or 62.4%. It is spread thinly across 30 manufacturers, the largest accounting for just 22.1%. Reporting peaked in 2023 at $2,731 and has fallen 69.3% since, to $838 in 2025.
Across 121 payments — averaging $60.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$2K
- Kerecis Limited$1K
- Treace Medical Concepts, Inc.$1K
- Trilliant Surgical LLC.$643
- Medshape, Inc.$403
- Paratek Pharmaceuticals, Inc.$379
- plus $2K from 24 others
What the payments were for
- Travel & lodging$2,76238%
- Food & beverage$4,59062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 10 | $1,623 |
| Kerecis Limited | 8 | $1,163 |
| Treace Medical Concepts, Inc. | 11 | $1,044 |
| Trilliant Surgical LLC. | 3 | $643 |
| Medshape, Inc. | 1 | $403 |
| Paratek Pharmaceuticals, Inc. | 14 | $379 |
| Amgen(2 entities) | 9 | $360 |
| Smith+Nephew | 15 | $281 |
| Melinta Therapeutics, LLC | 6 | $187 |
| Pylant Medical | 2 | $159 |
| Merck | 10 | $151 |
| Paragon 28, Inc. | 1 | $149 |
| Nevro Corp. | 7 | $148 |
| Davol Inc. | 2 | $115 |
| Organogenesis Inc. | 1 | $98 |
| Johnson & Johnson(2 entities) | 2 | $66 |
| Orthofix Medical, Inc. | 3 | $60 |
| Medtronic | 2 | $48 |
| Stryker | 1 | $35 |
| Integra Lifesciences Corporation | 1 | $34 |
| Bioventus LLC | 1 | $29 |
| Arthrosurface Incorporated | 1 | $27 |
| Nabriva Therapeutics, PLC | 2 | $24 |
| Biowound Solutions, Inc. | 2 | $23 |
| Mimedx Group, Inc. | 1 | $22 |
| Polynovo North America LLC | 1 | $20 |
| Averitas Pharma Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Arteriocyte Medical Systems, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$2,659
- Kerecis Omega3 Marigen$1,694
- Lapiplasty System$948
- Kerecis Omega3 GraftGuide$918
- Arsenal Ankle 10 Hole 1/3 Tubular Plate$643
- DynaNail$403
- KRYSTEXXA$240
- Portfolio$149
- VERSAJET II$125
- NUZYRA$117
- Baxdela$103
How this compares
$7,352 in reported general payments places this provider in the 75th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 57 | $1,703 |
| Pregabalin | 23 | $1,169 |
| Gabapentin | 60 | $651 |
| Ammonium Lactate | 21 | $562 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $266 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Fort Worth
- Gary BartholomewFort Worth$2K
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Fernando CruzCorsicana$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.